PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2024-07-25

Date Title Company
25-Jul-2024 KindlyMD(TM) Submits Comment to the Department of Justice Regarding Cannabis Rescheduling AccessWire
25-Jul-2024 Interactive Strength Inc.’s (Nasdaq: TRNR) CLMBR Earns Approved Vendor Partner status from Crunch Fitness and is Invited to the 2024 Crunch Franchise Convention AccessWire
25-Jul-2024 MIRA Pharmaceuticals Announces Positive Discovery of Ketamir-2’s Selective NMDA Binding Mechanism of Action AccessWire
25-Jul-2024 DiogenX strengthens executive committee with Hélène Sicard joining as Chief Development Officer Andrew Lloyd Associates
25-Jul-2024 ​​Biocair welcomes Syed Zaman as the new General Manager for India​ Biocair
25-Jul-2024 Global Osteotomy Plates Market: Forecast to Reach USD 615.5 Million by 2033 MARKITWIRED
25-Jul-2024 Global Sonohysterography Catheters Market Set to Surge to USD 22.2 Million by 2033 MARKITWIRED
25-Jul-2024 Global Compression Veterinary Bandages Market Set for Robust Growth, Forecast to Reach USD 161.1 Million by 2033 MARKITWIRED
25-Jul-2024 Global Visual Electrophysiology Market Set for Robust Growth with a 7.0% CAGR, Projected to Reach USD 458.9 Million by 2033 MARKITWIRED
25-Jul-2024 Global Stone Analysis Software Market Poised for Robust Growth, Projected to Reach USD 74.69 Million by 2033 MARKITWIRED
25-Jul-2024 Global Catheter-Directed Thrombolysis Market Poised for Remarkable Growth: Forecasted to Reach USD 808 Million by 2033 MARKITWIRED
25-Jul-2024 Global Lung Disease Therapeutics Market Set to Reach USD 152,369.26 Million by 2033 MARKITWIRED
25-Jul-2024 Global Medical Home Services Market Set for Remarkable Growth: Projected to Reach USD 605.5 Billion by 2033 MARKITWIRED
25-Jul-2024 Drägerwerk AG & Co. KGaA: Dräger on track to meet annual forecast after a solid first half-year Drägerwerk AG & Co. KGaA
25-Jul-2024 Lonza Nominates Juan Andres and Eric Drapé as Independent Board Members Lonza Group AG
25-Jul-2024 Curatis Holding AG: Initiation of Coverage and Publication of Equity Research Report by valuationLAB Curatis Holding AG
25-Jul-2024 Lonza Group H1 2024 Performance Well On Track to Deliver Full-Year Outlook: Sales Up 1.8% CER and 29.2% CORE EBITDA Margin Lonza Group AG